$18,724,367 $8,579,565
Adjustments to reconcile net income
to net cash provided by
(used in) operating activities:
Depreciation 1,040,924 228,833
Bad debt expenses -- --
Stock based compensation - make
good provision 9,838,354 --
Stock based compensation - stocks
to employees 9,945 --
(Increase) decrease in current assets:
Accounts receivable (7,731,421) 5,644,946
Other receivables, deposits and
prepaid expenses (8,466,631) (4,099,356)
Advance to suppliers (280,790) (11,484,067)
Inventories (9,223,710) (4,098,099)
Due from related party 623,581 (245,852)
Increase (decrease) in current
liabilities:
Accounts payable (187,219) (1,889,778)
Advance from customers 3,982,577 87,896
Taxes payable 592,462 (643,780)
Other payables and accrued expenses (217,054) 2,811,389
Net cash provided by (used in)
operating activities 8,705,385 (5,108,303)
CASH FLOWS FROM INVESTING ACTIVITIES:
Sale of investment -- --
Acquisition of property and
equipment (1,251,231) (6,809,173)
Construction in progress -- --
Net cash used in investing activities (1,251,231) (6,809,173)
CASH FLOWS FROM FINANCING ACTIVITIES:
Restricte
'/>"/>SOURCE China Bio Energy Holdings Group Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Related biology technology :1.
aTyr Pharma to Present at ChinaBio(R) Investor Forum in Hong Kong2.
Niusule Biotech Corp. Formally Establishes a New Venture to Import and Sell Health Foods in the Peoples Republic of China3.
China-Biotics, Inc. Appoints New Chief Financial Officer4.
China Medical Technologies Senior Management Purchased Company Shares5.
China Bio-Immunity Corporation - Rabies Vaccine Recall6.
China Medicine to Participate in 2009 Natural Products Expo West Trade Show7.
China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets8.
Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent9.
Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research10.
China Biologic Products High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan11.
OriGene Technologies, Inc. Establishes High Throughput Monoclonal Antibody Production Outsourcing Center in China